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151* Use of the Northern X-Ray scoring system over time in adult
CF patients
H. Burhan, M. Aldean, M.J. Ledson, M.J. Walshaw. Regional Adult CF Unit, The
Cardiothoracic Centre, Liverpool, United Kingdom
CF is a progressively destructive disease, and the longitudinal assessment of clinical
status is pivotal in managing individuals with the condition. Clinical scoring systems
can aid this process, and one commonly used in the UK (the Northern Score)
was introduced in 1994 and until recently this formed part of the annual data
recorded for every patient on the UK CF Trust database. However, although it has
been shown to have a good correlation with clinical parameters in cross sectional
studies, there are no data indicating its value over time in individual adult CF
patients. To assess this further, we compared the Northern score with spirometry
(FEV1%predicted), nutritional state (BMI) and IV antibiotic use (days/year) in a
group of adult CF patients attending our unit over a 7 year period between 1999 and
2005. Continuous data was available for 100 patients for at least 5 years over this
time. Relationships were explored both cross-sectionally and longitudinally using
the SPSS v.12 statistical package.
As expected, for cross sectional data, there was a signiﬁcant correlation be-
tween Northern score and IV antibiotic use (r = −0.397), BMI (r = −0.331), and
FEV1%predicted (r = −0.662) (all p< 0.01). For longitudinal data over a 5 year
period, there was a similar correlation between the change in Northern score and
deterioration in clinical parameters (BMI r = −0.209, p< 0.05; FEV1%predicted
r = −0.389, p< 0.01; IV antibiotic use r = 0.313, P< 0.01).
Thus, we have shown that the Northern score can be used to support the clinical
assessment of changes in physical state in adult CF patients over time. Although it
is now no longer required for the annual returns in the new UK CF Trust database,
clinicians may wish to continue its use as a valuable clinical tool.
152 Relationship between HRCT score, lung function and clubbing in
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Introduction: Patients with CF develop progressive lung disease as a result of
persistent infection and airway inﬂammation. CT abnormalities are variable and
include bronchiectasis, peribronchial wall thickening, mucous impaction and small
airway disease. The aim of this study was to evaluate whether routine clinical
parameters could predict the extent and pattern of lung disease seen on HRCT
scan.
Method: Over the past 3 years patients attending the Leeds Adult CF unit have
undergone routine chest CT scan to assess disease severity. Scans were scored for
a bronchiectasis (BS) and small airways disease (SAS). Data for FEV1, FVC, FEF
25−75, body mass index (BMI), severity of clubbing, intravenous (IV) antibiotic
courses, 6 minute walking test and pancreatic status were retrospectively collected.
Statistical analysis was performed using Spearman correlation and Mann-Whitney
tests (SPSS 12.0). P< 0.05 was regarded as statistically signiﬁcant.
Results: 69 consecutive HRCT scans were scored, median age (range) 22.7 years
(16.8−49.9). BS signiﬁcantly correlated with BMI, FEV1, FVC, FEF25−75 and
severity of clubbing. SAS had a signiﬁcant, but weaker correlation with FEV1,
FVC and FEF25−75, and demonstrated no relationship to BMI or clubbing. The
number of days of intravenous antibiotics following HRCT and 6 minute walk
distance only signiﬁcantly correlated with BS. CFRD and pancreatic insufﬁciency
were associated with higher BS and SAS (P< 0.05).
Conclusion: The best clinical predictors of bronchiectasis on HRCT would seem
to be clubbing, poor BMI, reduced 6 minute walking distance and a greater
requirement for IV antibiotic therapy. Spirometry measures do not seem to be
able to predict the presence of small airways disease.
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The mechanism underlying the onset of lung disease and early respiratory morbidity in
CF infants is poorly understood. The events in early life exert an important inﬂuence
on the outcome. Infant LFT are a non-invasive and reproducible technique that can
give precious data about the presence of bronchial obstruction.
Aim: evaluation of tidal breathing ﬂow-volume loops and FRC in asymptomatic infants
with CF in comparison to HS, performed with a respiratory function testing device
(Exhalizer® EcoMedics).
Methods: we studied 41 CF infants (23 males), aged 28.1±15.3 weeks and 37 HS
(21 males), aged 25.5±10.2 weeks; p = n.s. Tidal breathing parameters were measured:
RR (respiratory rate), VT/kg (tidal volume pro kg), Tptef/Te (ratio of time to reach
peak espiratory ﬂow in relation to total expiratory time). FRC was obtained with sulfur-
hexaﬂuoride (SF6) washin-washout technique using an ultrasonic ﬂow-meter. LFT were
performed during induced sleep (Chloral Hydrate 10% 50−75mg/kg os). Results are
shown in the table.
We observed that mean values of Tptef/Te were signiﬁcantly lower in CF infants than
in HS (p = 0.025) and mean values of FRC/kg were highest in CF patients (p< 0.0001).
Conclusions: air trapping and early airways obstruction are present in CF subjects
but not in healthy infants. Our ﬁndings suggest the presence of early functional
abnormalities in airways function in asymptomatic CF infants.
CF (Mean±SD) HS (Mean±SD) P
RR (br./min) 53.8±23.9 52.8±12 ns
VT (ml/kg) 7.53±1.45 6.9±1.2 ns
Tptef/Te (%) 21.9±12.4 28.6±13.5 <0.025
FRC/kg (ml/kg) 28.5±9.2 19.2±3.2 <0.0001
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Home monitoring using portable spirometers has gained increasing interest. The
aim of this pilot study was to evaluate Spirotel® in monitoring CF patients.
At home 4 CF patients (age 12−19 yrs) recorded ﬂow volume curves and symptoms
daily during 6 months. All were chronically colonized with P. aeruginosa and
inhaled TOBI (28 days on, 28 days off). FEV1 and symptoms such as cough, sputum
production, dyspnea, sleep disturbance and wheeze, scored as low/medium/high,
were evaluated. Cumulated scores of symptoms were calculated for each day. Slope
of regression curve of FEV1 data versus time over 6 months was calculated. Slope
of regression curve of FEV1 over sliding periods of the past 14 days were daily
determined (‘daily slope of FEV1’). Data were transferred each week by internet
using home telephone and internal modem and using a cable during a medical
visit. Compliance to TOBI inhalations was evaluated by SMS medication reminder
service. Patients were alerted by SMS on day 1 (start tobi) and day 28 (stop tobi)
during cycle ON TOBI. On day 28 patients send by sms number of vials not taken.
FEV1 change over 6 months ranged between −255 to +219ml/year or from
−13 to +13% predicted/year. Daily cumulated number of symptoms was 3−16.
No correlation was found between daily cumulated number of symptoms and
‘cumulative daily slope of FEV1’. Between 0 and 7 vials each cycle of TOBI
were forgotten.
Conclusion: Spirotel® allows home monitoring of lung function on a daily basis
(Telemedicine). No correlation was found between cumulative 14 days FEV1 and
reported symptoms. SMS reminder service is an elegant system to remind patient
of taking TOBI.
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